Nexalin Technology (NXL) Change in Accured Expenses (2022 - 2025)
Historic Change in Accured Expenses for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to -$47973.0.
- Nexalin Technology's Change in Accured Expenses fell 70871.72% to -$47973.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$48816.0, marking a year-over-year increase of 8640.39%. This contributed to the annual value of -$110539.0 for FY2024, which is 3240.78% up from last year.
- Latest data reveals that Nexalin Technology reported Change in Accured Expenses of -$47973.0 as of Q3 2025, which was down 70871.72% from -$21338.0 recorded in Q2 2025.
- In the past 5 years, Nexalin Technology's Change in Accured Expenses registered a high of $97322.0 during Q4 2022, and its lowest value of -$230747.0 during Q2 2024.
- Over the past 4 years, Nexalin Technology's median Change in Accured Expenses value was $5973.0 (recorded in 2023), while the average stood at -$16112.3.
- In the last 5 years, Nexalin Technology's Change in Accured Expenses skyrocketed by 31682.47% in 2023 and then tumbled by 396316.76% in 2024.
- Nexalin Technology's Change in Accured Expenses (Quarter) stood at $97322.0 in 2022, then tumbled by 336.95% to -$230607.0 in 2023, then skyrocketed by 107.76% to $17898.0 in 2024, then plummeted by 368.04% to -$47973.0 in 2025.
- Its Change in Accured Expenses was -$47973.0 in Q3 2025, compared to -$21338.0 in Q2 2025 and $2597.0 in Q1 2025.